Harrow (HROW) Receivables - Net (2014 - 2026)
Harrow's (HROW) quarterly Receivables - Net came in at $101.3 million in Q1 2026, up 31.4% year-on-year from $77.1 million in Q1 2025, and down 8.69% quarter-over-quarter from $110.9 million in Q4 2025.
Harrow (HROW) Receivables - Net (2014 - 2026) Analysis & Trends
Harrow's Receivables - Net history runs 13 years deep, the most recent figure standing at $101.3 million for Q1 2026.
- On a quarterly basis, Receivables - Net rose 31.4% year-over-year to $101.3 million in Q1 2026; TTM through Mar 2026 was $101.3 million, a 31.4% increase from a year earlier, with the FY2025 full-year figure at $110.9 million, down 4.71% from the prior year.
- Receivables - Net retreated to $101.3 million in Q1 2026 per HROW's latest filing, from $110.9 million in the prior quarter.
- Across five years, Receivables - Net topped out at $116.4 million in Q4 2024 and bottomed at $6.0 million in Q1 2022.
- The 5-year median for Receivables - Net is $29.0 million (2024), against an average of $46.5 million.
- Across the five-year window, Receivables - Net jumped 15522.5% in 2022 and slipped 4.71% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $6.2 million in 2022, then jumped by 194.37% to $18.4 million in 2023, then jumped by 532.63% to $116.4 million in 2024, then slipped by 4.71% to $110.9 million in 2025, then decreased by 8.69% to $101.3 million in 2026.
- Per Business Quant, the three latest HROW Receivables - Net figures stand at $101.3 million (Q1 2026), $110.9 million (Q4 2025), and $77.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.26 Mn |
| Mar 31, 2026 | 101.26 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Sep 30, 2025 | 77.60 Mn |
| Sep 30, 2025 | 77.60 Mn |
| Jun 30, 2025 | 78.82 Mn |
| Jun 30, 2025 | 78.82 Mn |
| Mar 31, 2025 | 77.06 Mn |
| Mar 31, 2025 | 77.06 Mn |
| Dec 31, 2024 | 116.37 Mn |
| Dec 31, 2024 | 116.37 Mn |
| Sep 30, 2024 | 53.73 Mn |
| Sep 30, 2024 | 53.73 Mn |
| Jun 30, 2024 | 52.73 Mn |
| Jun 30, 2024 | 52.73 Mn |
| Mar 31, 2024 | 28.96 Mn |
| Mar 31, 2024 | 28.96 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Dec 31, 2023 | 18.40 Mn |